financetom
Business
financetom
/
Business
/
Amazon vs Future Group: Supreme Court stays proceedings, offers relief to FRL, FCPL
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Amazon vs Future Group: Supreme Court stays proceedings, offers relief to FRL, FCPL
Sep 9, 2021 4:10 AM

The Supreme Court of India has stayed all proceedings for attachment of Future Coupons (FCPL) and Future Retail (FRL) assets pending before the Delhi High Court on Thursday, giving relief to Future Group. The court also issued notice on a plea by Future Group against Delhi HC's order of attachment.

Earlier in March 2021, Delhi HC had directed for attachment of assets of FRL and Future Coupons FCPL. HC had earlier directed that failure to secure a stay from the SC will cause it to enforce its order.

The apex court said it is trying to balance the interests of all the stakeholders and directed markets regulator SEBI and competition watchdog CCI to not pass final orders on approval on the deal for four weeks.

Speaking for FRL, advocate Harish Salve said e-commerce giant Amazon invoked the arbitration under the agreement with FCPL, "FRL is not a party to the arbitration agreement."

ALSO READ | Future-Amazon deal: A long term call option granted could throw spanner in your own works

Regardless, Amazon would be violating rules if it is held Amazon has any interest in FRL, the "government has not allowed FDI in multi-brand retail," he argued.

In March, besides restricting FRL from going ahead with its deal with Reliance Retail, Justice Midha had imposed costs of Rs 20 lakh on the Future Group and others associated with it and ordered attachment of their properties. The court had asked the parties to file an affidavit detailing their assets within one month and show cause as to why they are not detained under civil prison for three months for violating the emergency arbitrator's orders.

Earlier this month, the Supreme Court held that Singapore's Emergency Arbitrator (SEA) order is enforceable. It had pronounced the verdict in favour of Amazon and against the merge of FRL with Reliance Retail. The court had also held the EA award, restraining the Rs 24,731 deal.

ALSO READ | Amazon vs Future Retail: A timeline of how events unfolded

(Edited by : Yashi Gupta)

First Published:Sept 9, 2021 1:10 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Halozyme Therapeutics Says Roche's OCREVUS SC With ENHANZE Gets European Commission Approval
Halozyme Therapeutics Says Roche's OCREVUS SC With ENHANZE Gets European Commission Approval
Jun 25, 2024
04:41 AM EDT, 06/25/2024 (MT Newswires) -- Halozyme Therapeutics ( HALO ) said Tuesday that Roche received European Commission marketing authorization of OCREVUS SC co-formulated with ENHANZE, Halozyme's proprietary recombinant human hyaluronidase enzyme, for the treatment of relapsing multiple sclerosis and primary progressive multiple sclerosis. OCREVUS SC is a 10-minute injection that maintains the same twice-yearly schedule as the approved...
OpenAI to cut access to tools for developers in China and other regions, Chinese state media says
OpenAI to cut access to tools for developers in China and other regions, Chinese state media says
Jun 25, 2024
BEIJING, June 25 (Reuters) - ChatGPT maker OpenAI is planning to block access to technology used to build artificial intelligence products for entities in China and some other countries, a Chinese state-owned newspaper reported on Tuesday. ChatGPT is not available in mainland China but many Chinese startups have been able to access OpenAI's application programming interface (API) platform and use...
--Nvidia Shares Attempt Rebound Premarket Tuesday After Closing 6.7% Lower Monday
--Nvidia Shares Attempt Rebound Premarket Tuesday After Closing 6.7% Lower Monday
Jun 25, 2024
04:47 AM EDT, 06/25/2024 (MT Newswires) -- Price: 116.57, Change: +0.93, Percent Change: +0.84 ...
Novo Nordisk's Wegovy weight-loss drug approved in China
Novo Nordisk's Wegovy weight-loss drug approved in China
Jun 25, 2024
SHANGHAI (Reuters) -Novo Nordisk said on Tuesday its popular weight-loss drug Wegovy has been approved in China, paving the way for sales in the world's second-largest economy. Novo said in March that it would initially target Chinese patients willing to pay out-of-pocket for the weekly injectable drug. The company did not immediately respond to a Reuters request for comment on...
Copyright 2023-2025 - www.financetom.com All Rights Reserved